"Making Sure Medicine Works For Everyone By Unlocking The Power of Diversity"

Welcome To Biscayne Clinical Research

In April of 2022 the FDA outlined its initiative to increase diversity in clinical trials for all medical products.

We believe our site is well suited to address these FDA initiatives. Biscayne Clinical Research is a minority-owned organization with a minority-PI and a diverse patient population of over 90% African Americans, which in part comes from the Caribbean basin. With this diversity, we bring a unique perspective to help FDA achieve their diversity objectives in medicine. Our team has extensive experience conducting studies that affect this community, ranging from vaccines, hypertension, obesity, asthma, women's health studies, diabetes to COPD.

Our database is highly diverse, enabling us to fill many protocols, and we use biometrics to reduce the possibility of dual enrollment. We have an 8,000 square foot office with highly experienced PI and clinical staff. We can negotiate the budget while simultaneously completing regulatory start-up to considerably increase FPI.


Responsive Videos

Site Tour

Message from Our PI

5

Therapeutic Areas

25

Years of Experience

50

Trials Conducted

20000

Patient Database

Why Choose Us

Experience
  • Over 50 successful Clinical Trials
  • Reduced Study Startup Timeline
  • Experienced Coordinators Team
  • Recruitment
  • Top 5 Enrolling Site
  • Diverse Patient Database
  • Large African American Database
  • Facility
  • 7,300 Square Feet
  • Crash Cart
  • 100 Feet from Hospital
  • Technology
  • Remote Temperature Monitoring
  • Biometrics Guarding From Dual Enrollment


  • Start Up Process

    Feasibility questionnaires are turned around in 48 hours or less. Providing historical enrollment metrics allows feasibility and site identification to occur at an accelerated pace. In order to help our sponsors, reduce study start up timelines, ICR offers a more proactive, streamlined approach to the negotiating process. Contract and Budget Negotiations within 2 weeks whiles we begin the IRB process.

    Site Demographics Overview

    BCR database includes metrics from PIs and Sub-I(s). This diverse database gives us the ablility, to forcast and plan enrollment, focus on required demographics of each protocol.

    65%

    African American

    20%

    Carribean Basin

    10%

    White

    5%

    Hispanic Descent

    FDA Diversity Initiative



    People from racial and ethnic minority and other diverse groups are often underrepresented in clinical research. The FDA encourages diverse participation in clinical trials, and encourages people to talk to their health care provider if they think a clinical trial may be right for them.

    Can I Participate

    Yes, you can. To participate in a given study you must qualify by meeting the research criteria. Eligibility can be determined by good health or specific medical diagnosis, as well as age, gender, and current medication.

    Why Volunteer

    Volunteering contributes to the advancement of medical knowledge and treatments.These Trials carefully designed medical activities that allow the evaluation of safety and efficacy of new medication

    Send Us Message

    We look forward from hearing from you. Send us a message today.